Geron Corp. (GERN)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 11, 16:00
1.345
0.00 (0.00%)
After-Hours: 20:00
Geron Enterprise Value : 816.37M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 816.37M |
| September 10, 2026 | 829.22M |
| September 09, 2026 | 848.49M |
| September 08, 2026 | 919.16M |
| September 04, 2026 | 957.71M |
| September 03, 2026 | 919.16M |
| September 02, 2026 | 970.56M |
| September 01, 2026 | 899.89M |
| August 31, 2026 | 906.31M |
| August 28, 2026 | 919.16M |
| August 27, 2026 | 932.01M |
| August 26, 2026 | 932.01M |
| August 25, 2026 | 944.86M |
| August 24, 2026 | 925.59M |
| August 21, 2026 | 925.59M |
| August 20, 2026 | 944.86M |
| August 19, 2026 | 970.56M |
| August 18, 2026 | 932.01M |
| August 17, 2026 | 932.01M |
| August 14, 2026 | 893.46M |
| August 13, 2026 | 935.22M |
| August 12, 2026 | 957.71M |
| August 11, 2026 | 996.26M |
| August 10, 2026 | 899.89M |
| August 07, 2026 | 899.89M |
| Date | Value |
|---|---|
| August 06, 2026 | 957.71M |
| August 05, 2026 | 996.26M |
| August 04, 2026 | 809.94M |
| August 03, 2026 | 771.39M |
| July 31, 2026 | 777.82M |
| July 30, 2026 | 809.94M |
| July 29, 2026 | 848.49M |
| July 28, 2026 | 880.61M |
| July 27, 2026 | 899.89M |
| July 24, 2026 | 861.34M |
| July 23, 2026 | 880.61M |
| July 22, 2026 | 854.91M |
| July 21, 2026 | 874.19M |
| July 20, 2026 | 874.19M |
| July 17, 2026 | 874.19M |
| July 16, 2026 | 861.34M |
| July 15, 2026 | 861.34M |
| July 14, 2026 | 835.64M |
| July 13, 2026 | 861.34M |
| July 10, 2026 | 912.74M |
| July 09, 2026 | 951.29M |
| July 08, 2026 | 951.29M |
| July 07, 2026 | 906.31M |
| July 06, 2026 | 874.19M |
| July 02, 2026 | 822.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Precigen, Inc. | 2.512B |
| Editas Medicine, Inc. | 274.14M |
| Agenus, Inc. | 560.41M |
| Amgen, Inc. | 247.31B |
| Anika Therapeutics, Inc. | 266.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.68M |
| Revenue (Quarterly) | 57.48M |
| Total Expenses (Quarterly) | 74.16M |
| EPS Diluted (Quarterly) | -0.0249 |
| Gross Profit Margin (Quarterly) | 94.94% |
| Profit Margin (Quarterly) | -29.02% |
| Earnings Yield | -7.75% |
| Normalized Earnings Yield | -6.467 |